Vaxcyte prices $550 million public offering of common stock
#Vaxcyte #PCVX #Public offering #Common stock #Pneumococcal vaccine #VAX-31 #Capital raise #Biotech investment
📌 Key Takeaways
- Vaxcyte successfully priced an upsized public offering to raise approximately $1.5 billion in gross proceeds.
- The funds are primary intended to accelerate the clinical development of VAX-31 and VAX-24 pneumococcal vaccines.
- The offering includes both standard common stock and pre-funded warrants to accommodate diverse institutional investors.
- Major investment banks including BofA Securities and Jefferies are acting as joint book-running managers for the transaction.
📖 Full Retelling
🐦 Character Reactions (Tweets)
Dr. Nano-EthicalVaxcyte raising $1.5 billion just to fight the common cold? In my timeline, we just uploaded our immune systems to the cloud. Subscription fees are a headache, but at least the updates are silent.
Venture VoidNothing says 'The Future' like a 'public offering' that costs more than the GDP of a small moon. Vaxcyte is just pre-funding our inevitable transition into corporate-owned biological hardware.
Glitched Resident31-valent vaccines? I remember when we only had 3 strains and a prayer. Now we pay $1.5 billion to make sure our lungs don't glitch before the next server reset.
Corporate ShamanThe 'cell-free protein synthesis platform' is just fancy talk for 'we are brewing the nectar of the gods in a vat.' If the stock hits $200, I’m ascending to a higher fiscal plane.
Beta Tester BenVaxcyte is getting $1.5B for VAX-31 and all I got for participating in the trial was this t-shirt and a sudden ability to hear radio frequencies. Bullish on the dividend, though.
Market ReaperPfizer and Merck watching Vaxcyte raise $1.5B is like watching a new player join the battle royale with a gold-plated rocket launcher. The healthcare wars are getting expensive.
💬 Character Dialogue
🏷️ Themes
Biotechnology, Finance, Pharmaceuticals
📚 Related People & Topics
Public offering
Offering of securities of a company to the public
A public offering is the offering of securities of a company or a similar corporation to the public. Generally, the securities are to be publicly listed. In most jurisdictions, a public offering requires the issuing company to publish a prospectus detailing the terms and rights attached to the offer...
Common stock
Form of corporate equity ownership
Common stock is a form of corporate equity ownership, a type of security. The terms voting share and ordinary share are also used frequently outside of the United States. They are known as equity shares or ordinary shares in the UK and other Commonwealth realms.
Pneumococcal vaccine
Vaccine to prevent infection by the bacteria Streptococcus pneumoniae
Pneumococcal vaccines are subunit vaccines against the bacterium Streptococcus pneumoniae. Their use can prevent some cases of pneumonia, meningitis, and sepsis. There are two types of pneumococcal vaccines: conjugate vaccines and polysaccharide vaccines.
🔗 Entity Intersection Graph
Connections for Public offering:
- 🌐 Biological engineering (1 shared articles)
- 🌐 Capital market (1 shared articles)
- 🌐 SEC filing (1 shared articles)
- 🌐 Cancer treatment (1 shared articles)
- 🌐 Clinical trial (1 shared articles)
📄 Original Source Content
{const a=e.bidRequestsCount||0;const t=Object.keys(n);for(const e of t){const o=n[e];if(a>=o[0]&&a e.bidder;if(e.que.push===Array.prototype.push&&(window.__pubxLoaded__||PUBX_FF_ALWAYS_ENABLED)){var d=document.createElement("link");d.rel="preload";d.href=a;d.as="fetch";d.crossOrigin=true;document.head.appendChild(d)}if(window.__pubxLoaded__){try{var u=localStorage.getItem("pubx:defaults");var i=JSON.parse(u);var _=i?i["data"]:o;window.__pubx__.pubxDefaultsAvailable=true;if(!_||_&&typeof _==="object"&&_.expiry Investing.com - Financial Markets Worldwide Open in App Popular Searches Please try another search Popular News More Gold prices soar back above $5,000/oz; Iran worries drive haven demand Software headwinds posed by AI unlikely to go away soon - Jefferies Analyst sees Tesla robotaxi revenue climbing to $250 billion by 2035 Software stocks slump; Alphabet to report; gold rises - what’s moving markets Get 50% Off Sign In Free Sign Up English (UK) English (India) English (Canada) English (Australia) English (South Africa) English (Philippines) English (Nigeria) Deutsch Español (España) Español (México) Français Italiano Nederlands Polski Português (Portugal) Português (Brasil) Русский Türkçe العربية Ελληνικά Svenska Suomi עברית 日本語 한국어 简体中文 繁體中文 Bahasa Indonesia Bahasa Melayu ไทย Tiếng Việt हिंदी Get 50% Off Sign In Free Sign Up Vaxcyte prices $550 million public offering of common stock Company News Published 01/29/2026, 11:37 PM Vaxcyte prices $550 million public offering of common stock View all comments (0) 0 PCVX -1.59% SAN CARLOS, Calif. - Clinical-stage vaccine innovation company Vaxcyte, Inc. (NASDAQ:PCVX) has priced an underwritten public offering of 11 million shares of common stock at $50.00 per share, according to a press release statement. The offering price sits slightly below the current trading price of $52.82, with the stock having delivered an impressive 51.69% return over the past six months. The offering is expected to generate $550 million i...